Skip to content

HMGB1/MYH9 suppresses PPARγ to induce lung injury in renal ischemia-reperfusion: protective effects of Rosiglitazone.

Aug 2026 · Pediatric Research · 0 citations · 56 references
Medicine

TL;DR

Clinically, elevated urinary CCL2 in critically ill children associates with higher risk of concurrent AKI/ALI and poorer prognosis, indicating CCL2 as a biomarker for treatment response and prognosis.

View source

Similar papers

Review Open access Aug 2026

Targeting HMGB1 for Renal Ischemia and Reperfusion Injury: Mechanisms and Therapeutic Strategies

Although the underlying mechanisms of renal IRI have been extensively studied, the corresponding effective treatments are still lacking. HMGB1, an important nuclear factor that is secreted outside cells when experiencing stress conditions, acts as a DAMP and exerts crucial effects on renal IRI. Many studies have sugges...

Xiao-Hui Chi, Ming-Feng Liao, Ya-Qun Zhou · 0 citations
Open access Aug 2026

Sufentanil attenuates LPS-induced acute lung injury by suppressing ferroptosis and maintaining GPX4 protein abundance

Introduction Acute lung injury (ALI) is a severe inflammatory syndrome characterized by disruption of the alveolar-capillary barrier, pulmonary edema, and impaired gas exchange. Ferroptosis has emerged as an important contributor to ALI pathogenesis, but the mechanisms associated with reduced glutathione peroxidase 4 (...

Xiao-Yun Guo, Wei-Feng Yan, Wen-Yong Peng et al. · 0 citations
Oct 2026

GLS2 Promotes Early Ferroptosis Followed by Apoptosis and p53 Signaling in Renal Ischemia-Reperfusion Injury.

Renal ischemia-reperfusion injury (IRI) is a major cause of acute kidney injury (AKI), particularly in the settings of kidney transplantation and perioperative care. In IRI-induced AKI, ferroptosis, an iron-dependent, lipid peroxidation-driven form of regulated cell death, occurs early in proximal tubular epithelial ce...

Kazuki Ishiwata, Sawako Suzuki, Chi-Wei Lee et al. · 0 citations
Sep 2026

Farrerol alleviates hepatic ischemia-reperfusion injury by regulating the CD14/MyD88/NF-κB signaling pathway.

Hepatic ischemia-reperfusion injury (HIRI) remains a critical complication in liver surgery with limited pharmacological options, and while Farrerol (FA), a natural dihydroflavone, has shown protective effects in other organ IR models, its role in HIRI has never been explored. In this study, we established a murine mod...

Hong-Liang Liang, Jian-Sen Lu, Hao Pan et al. · 0 citations
Open access Sep 2026

Sirtuin 3 attenuates sepsis-induced acute lung injury by suppressing NF-κB/NLRP3/GSDMD-mediated pyroptotic signaling.

BACKGROUND Sepsis is a major global health threat and frequently leads to acute lung injury (ALI). Pyroptosis has been increasingly implicated in the inflammatory progression of sepsis-induced ALI. Sirtuin 3 (Sirt3), a mitochondrial deacetylase, can regulate inflammatory injury and cellular stress responses. However, i...

Wei-Jian Zhang, Nan Gao, Song Yang et al. · 0 citations
Open access Sep 2026

A novel Keap1-Nrf2 inhibitor 6K delays the progression of AKI-to-CKD by mitigating maladaptive repair

Severe or recurrent acute kidney injury (AKI) is a critical risk factor for chronic kidney disease (CKD) progression, characterized by irreversible fibrosis and limited therapeutic options. Maladaptive repair in proximal tubular epithelial cells (PTECs) during AKI-to-CKD progression is crucial, with the oxidative stres...

Yi-Ming Wang, Yi Sun, Ting Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.